Cargando…

Author Correction: Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk

Detalles Bibliográficos
Autores principales:	Šimják, Patrik, Petr, Tomáš, Kaslová, Barbora, Fejfar, Tomáš, Hůlek, Petr, Pařízek, Antonín, Vítek, Libor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758151/ https://www.ncbi.nlm.nih.gov/pubmed/36526705 http://dx.doi.org/10.1038/s41598-022-26431-4

Ejemplares similares

Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk
por: Šimják, Patrik, et al.
Publicado: (2022)

Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
por: Krajina, Antonin, et al.
Publicado: (2012)

Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress
por: Muchova, Lucie, et al.
Publicado: (2011)

Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart
por: Hanafi, Noorul Izzati, et al.
Publicado: (2018)

Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice
por: Winston, Jenessa A., et al.
Publicado: (2021)

Strong activation of bile acid-sensitive ion channel (BASIC) by ursodeoxycholic acid
por: Wiemuth, Dominik, et al.
Publicado: (2013)

A Comprehensive Evaluation of Steroid Metabolism in Women with Intrahepatic Cholestasis of Pregnancy
por: Pařízek, Antonín, et al.
Publicado: (2016)

Investigation of 23 Bile Acids in Liver Bile in Benign and Malignant Biliary Stenosis: A Pilot Study
por: Rejchrt, Stanislav, et al.
Publicado: (2019)

Iron overload reduces synthesis and elimination of bile acids in rat liver
por: Prasnicka, Alena, et al.
Publicado: (2019)

The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid
por: Geenes, Victoria, et al.
Publicado: (2014)

Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity
por: Zhang, Yunjing, et al.
Publicado: (2019)

The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis
por: Lajczak‐McGinley, Natalia K., et al.
Publicado: (2020)

Establishing the Optimal Time for Induction of Labor in Women with Diet-Controlled Gestational Diabetes Mellitus: A Single-Center Observational Study
por: Šimják, Patrik, et al.
Publicado: (2022)

Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy
por: Ovadia, Caroline, et al.
Publicado: (2020)

Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
por: Marchesi, Elena, et al.
Publicado: (2023)

Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
por: Kim, Da Jung, et al.
Publicado: (2019)

Enzymatic methods may underestimate the total serum bile acid concentration
por: Žížalová, Kateřina, et al.
Publicado: (2020)

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
por: Mueller, Michaela, et al.
Publicado: (2015)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Successful treatment of an infant with congenital bile acid synthesis disorder type 3 by ursodeoxycholic acid: a case report
por: Mo, Weiqian, et al.
Publicado: (2022)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition
por: Ueda, Hajime, et al.
Publicado: (2022)

Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models
por: Cui, Yunfeng, et al.
Publicado: (2012)

Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
por: Huang, Tzu-En, et al.
Publicado: (2020)

High-fat diets enhance and delay ursodeoxycholic acid absorption but elevate circulating hydrophobic bile salts
por: Huang, Liang, et al.
Publicado: (2023)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Hepatic bile acids and bile acid-related gene expression in pregnant and lactating rats
por: Zhu, Qiong N., et al.
Publicado: (2013)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

Characterization of Metabolic Correlations of Ursodeoxycholic Acid with Other Bile Acid Species through In Vitro Sequential Metabolism and Isomer-Focused Identification
por: Li, Wei, et al.
Publicado: (2023)

Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study
por: Lee, Jin, et al.
Publicado: (2022)

Author Correction: Chronic kidney disease and pregnancy outcomes
por: Dvořák, Jan, et al.
Publicado: (2021)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

Ursodeoxycholic acid production by Gibberella zeae mutants
por: Kollerov, Vyacheslav, et al.
Publicado: (2022)

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies
por: Tschirner, Anika, et al.
Publicado: (2012)

Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones
por: Chang, Hai-Yang, et al.
Publicado: (2018)

Adding ursodeoxycholic acid to the endoscopic treatment and common bile duct stenting for large and multiple biliary stones: Will it improve the outcomes?
por: Hormati, Ahmad, et al.
Publicado: (2020)

Influence of ursodeoxycholic acid on blood glucose, insulin and GLP-1 in rats with liver fibrosis induced by bile duct ligation
por: Bai, Xiu-Ping, et al.
Publicado: (2023)

Author Correction: Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
por: Romero-Ramírez, Lorenzo, et al.
Publicado: (2022)

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022)

Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects
por: Murakami, Masanori, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1768g21a9r484na876nqi06n6l